Covance
Advertisement
Articles by Covance
This whitepaper discusses the importance of patient support programs and why a robust risk mitigation plan is critical to ensure that patients receive their therapy during crises.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
2
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
3
Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act
4
Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche
5